Thailand: Thailand's National Biopharmaceutical Facility (NBF) has invited Malaysian government agencies, researchers, and academic institutions to collaborate in strengthening biopharmaceutical research, innovation, and manufacturing capabilities for the benefit of the ASEAN region.
According to BERNAMA News Agency, Dr. Warinthorn Songkasiri, the acting director of NBF, emphasized the facility's commitment to fostering strategic partnerships that support the development of scientific expertise, skilled talent, advanced technologies, and industrial capabilities across the region. The NBF serves as Thailand's National Vaccine Security Facility and plays a crucial role in the country's biopharmaceutical industry, focusing on enhancing research, development, and manufacturing capabilities to prepare for future public health challenges.
Dr. Warinthorn, who also serves as vice-president for Research Strategy at King Mongkut's University of Technology Thonburi (KMUTT), highlighted Malaysia's strong expertise in healthcare, medical research, and higher education, which makes it a valuable partner in advancing regional biopharmaceutical development. She suggested that the collaboration could encompass joint research projects, technology transfer, workforce development, knowledge exchange, and industrial partnerships aimed at accelerating innovation and improving regional health security.
The NBF offers comprehensive infrastructure through its centers of excellence, enabling researchers and industry players to translate scientific discoveries into commercially viable products. Dr. Annop Nophatarana, KMUTT vice-president, described the NBF as more than just a research center. He stated that it is a strategic national infrastructure that bridges scientific research with industrial application, thereby strengthening Thailand's healthcare security, enhancing national competitiveness, and supporting the sustainable growth of the country's biopharmaceutical industry.
The media visit to NBF was part of the International Healthcare Week (IHW) 2026 program, which highlights Thailand's growing capabilities in healthcare innovation, medical technology, and biopharmaceutical manufacturing. Media representatives from Malaysia, Indonesia, the Philippines, and Vietnam also visited Praram 9 Hospital, which showcases Thailand's excellence in healthcare delivery through internationally recognized standards of quality, patient safety, and clinical excellence. The hospital offers more than 40 medical specialties, supported by over 300 medical specialists, providing comprehensive multidisciplinary care across a broad spectrum of medical conditions.